Table 1.
Clinical Characteristics of AML Patients
Characteristics | Overall Cohort (n=134) | ||
---|---|---|---|
Favorable | Intermediate/Normal | Poor | |
(n=17) | (n=91) | (n=26) | |
Sex (male/female) | 9/8 | 45/46 | 10/16 |
Age: median (range) | 52 (22–77) | 58 (21–88) | 63.5 (18–88) |
Peripheral blast, % median (range) | 61 (35–90) | 72 (0–98) | 60 (30–99) |
Bone marrow blast, % median (range) | 54 (0–86) | 37 (0–97) | 60 (30–99) |
WBC count (109/L) median (range) | 22 (2–57) | 20 (1–203) | 11 (1–90) |
Hemoglobin (g/dL) median (range) | 9 (7–11) | 10 (6–14) | 9 (7–13) |
Platelet count (109/L) median (range) | 40 (9–149) | 52 (8–351) | 38 (9–148) |
FAB classification | |||
M0 | 0 | 7 | 7 |
M1 | 4 | 25 | 6 |
M2 | 6 | 20 | 7 |
M4 | 6 | 23 | 4 |
M5 | 0 | 14 | 0 |
M6 | 0 | 1 | 1 |
M7 | 1 | 1 | 1 |
Cytogenetic abnormality | |||
t(8;21) | 7 | 0 | 0 |
inv(16) | 7 | 0 | 0 |
Trisomy 8 | 0 | 0 | 6 |
Complex | 0 | 0 | 16 |
Abbreviations: AML, acute myeloid leukemia; WBC, white blood cell; FAB, French-American-British.